Advances in Clinical Chemistry

Erscheinungsjahr 2021
ISBN: 978-0-12-824614-6
Verlag: William Andrew Publishing

Buch, Englisch, 356 Seiten, Format (B × H): 152 mm x 229 mm, Gewicht: 680 g

Advances in Clinical Chemistry, Volume 102, the latest installment in this internationally acclaimed series, contains chapters authored by world-renowned clinical laboratory scientists, physicians and research scientists. The serial discusses the most up-to-date technologies related to the field of clinical chemistry. Chapters in this new release cover Advances in immunosensor technology, Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury, Oxidative stress biomarkers in the preterm infant, Translational biomarkers in the era of precision medicine, Metabolomics applications in coronary artery disease personalized medicine, Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers.

Zielgruppe

Clinical Laboratory Professionals, Physicians and Research Scientists

Autoren/Hrsg.

Makowski, Gregory S.

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)

Inhaltsverzeichnis

1. Advances in immunosensor technology Muhammet Aydin, Elif Burcu Aydin and Mustafa Kemal Sezgintürk 2. Extracellular Vesicles: Roles and Applications in Drug-Induced Liver Injury David S. Umbaugh and Hartmut Jaeschke 3. Oxidative stress biomarkers in the preterm infant Angel Sanchez-Illana, Jose David Pineiro-Ramos, Victoria Ramos-Garcia, Isabel Ten-Domenech, Maximo Vento and Julia Kuligowski 4. Translational biomarkers in the era of precision medicine Laura Bravo-Merodio, Animesh Acharjee, Dominic Russ, Vartika Bisht, John A. Williams, Loukia G. Tsaprouni and Georgios V. Gkoutos 5. Metabolomics applications in coronary artery disease personalized medicine Arwa M. Amin 6. Quantitative EEG biomarkers for epilepsy and their relation to chemical biomarkers Yvonne Holler and Raffaele Nardone

Über Autor(innen)

Makowski, Gregory S.
Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.